Autism spectrum disorder nursing: complete reference for students

LS
By Lindsay Smith, AGPCNP
Updated April 30, 2026

Autism spectrum disorder (ASD) is a neurodevelopmental condition defined by persistent deficits in social communication and social interaction, combined with restricted, repetitive patterns of behavior, interests, or activities. It is present from early development, though it may not become fully apparent until social demands exceed the person’s capacity to meet them. The CDC estimates that 1 in 36 children in the United States has ASD — making it one of the most commonly encountered neurodevelopmental conditions in clinical nursing practice.

For nurses, ASD is significant across the lifespan. Children with ASD are admitted for seizures, surgical procedures, gastrointestinal issues, and behavioral crises. Adults with ASD present to emergency departments with anxiety, depression, self-injury, and medical conditions that may be difficult to communicate. In every setting, the nurse’s ability to adapt the environment and communication style directly affects care quality, patient safety, and family trust.

This reference covers the DSM-5 diagnostic framework, etiology, clinical presentation across the spectrum, nursing assessment, evidence-based interventions, pharmacological management, and transition-to-adulthood considerations. Fifteen NCLEX high-yield tips are provided at the end.


ASD at a glance

Feature Detail
Prevalence 1 in 36 children (CDC, 2023); male:female ratio approximately 4:1
Core DSM-5 domains 1. Persistent social communication/interaction deficits; 2. Restricted/repetitive behaviors, interests, or activities
Onset Symptoms present in early developmental period; may not fully manifest until social demands increase
Severity levels Level 1 (requiring support), Level 2 (requiring substantial support), Level 3 (requiring very substantial support)
Etiology Multifactorial; heritability ~80%; no causal link to vaccines
Intellectual disability comorbidity ~30% of individuals with ASD also have intellectual disability; ~70% do not
Seizure disorder comorbidity ~20–25% of individuals with ASD; see seizure nursing reference
FDA-approved medications for ASD Risperidone (irritability, ages 5+) and aripiprazole (irritability, ages 6+) — no medication treats core ASD symptoms
Primary evidence-based intervention Applied Behavior Analysis (ABA)
Key safety concern Elopement/wandering — up to 49% of children with ASD elope at some point

DSM-5 diagnostic criteria

The DSM-5 (2013) consolidated all prior subtypes — autistic disorder, Asperger’s disorder, and pervasive developmental disorder not otherwise specified (PDD-NOS) — into a single diagnosis: autism spectrum disorder. This is a high-yield NCLEX fact.

Diagnosis requires meeting all criteria in Domain A and at least two of four criteria in Domain B:

Domain Criterion Examples
A — Social communication and interaction
(all three required)
A1: Deficits in social-emotional reciprocity Reduced back-and-forth conversation; failure to initiate or respond to social interactions; difficulty sharing emotions
A2: Deficits in nonverbal communicative behaviors Reduced eye contact; limited use or understanding of gestures; lack of facial expressions during communication
A3: Deficits in developing and maintaining relationships Difficulty adjusting behavior to social context; limited interest in peers; absence of imaginative play
B — Restricted/repetitive behaviors
(at least two of four required)
B1: Stereotyped or repetitive motor movements, use of objects, or speech Motor stereotypies (hand flapping, rocking); lining up objects; echolalia; idiosyncratic phrases
B2: Insistence on sameness; inflexible adherence to routines Extreme distress at small changes; rigid thinking patterns; ritualized greeting behaviors; same food only
B3: Highly restricted, fixated interests Intense preoccupation with specific topics; unusual objects of interest; excessive focus
B4: Hyper- or hyporeactivity to sensory input Apparent indifference to pain or temperature; adverse responses to specific sounds or textures; visual fascination with lights or movement
C — Timing Symptoms present in early developmental period May not fully manifest until social demands exceed capacity
D — Functional impact Symptoms cause significant impairment in social, occupational, or other areas
E — Not better explained by Intellectual disability alone or global developmental delay ASD and intellectual disability can coexist; requires both diagnoses to be met independently

Severity levels

Severity is rated separately for social communication and for restricted/repetitive behaviors:

  • Level 1 — Requiring support: Without support, noticeable deficits in social communication; some difficulty with flexibility and organization
  • Level 2 — Requiring substantial support: Marked deficits in verbal and nonverbal communication; social impairments apparent even with support; distress is obvious at changes
  • Level 3 — Requiring very substantial support: Severe deficits in verbal and nonverbal communication; very limited initiation of interaction; inflexibility causes extreme difficulty functioning

Epidemiology and etiology

Who is affected

ASD affects approximately 1 in 36 children in the US (CDC ADDM Network, 2023), up from 1 in 44 (2021 data). The increase reflects improved awareness, broader diagnostic criteria, and better access to evaluation rather than a true increase in underlying prevalence.

The male-to-female ratio is approximately 4:1. Females with ASD are frequently underdiagnosed because they tend to “camouflage” social difficulties more effectively, masking symptoms that might prompt earlier evaluation in males.

Etiology

ASD is multifactorial with a strong genetic basis:

  • Heritability is estimated at approximately 80%, based on twin and family studies. Multiple genes are implicated; no single gene causes ASD in the majority of cases
  • De novo mutations (new mutations not inherited from either parent) account for a portion of cases, particularly in individuals without family history
  • Environmental factors under investigation include advanced parental age, prenatal exposure to certain medications (valproate), preterm birth, and gestational diabetes — these are associated factors, not established causes
  • Vaccines do not cause autism. The original 1998 Wakefield study claiming an MMR–ASD link was retracted, found to be fraudulent, and the author’s medical license was revoked. Subsequent large-scale studies involving millions of children across multiple countries have firmly established no causal link between vaccines and ASD. This is tested on NCLEX and important to communicate to families.

Clinical presentation

Social communication and interaction

Social communication deficits vary widely across the spectrum. In a clinical setting, nurses may observe:

  • Reduced or absent eye contact
  • Failure to respond to name
  • Delayed or absent spoken language (in more severely affected individuals); some may be nonverbal
  • Echolalia — repeating words or phrases heard previously, sometimes in context, sometimes not
  • Difficulty initiating or maintaining two-way conversation
  • Literal interpretation of language — idioms, sarcasm, and figurative speech may be confusing or taken at face value (“You’re pulling my leg” may prompt the person to look at their leg)
  • Difficulty understanding others’ emotions or perspective (theory of mind differences)

Restricted and repetitive behaviors

  • Stereotypies: Repetitive motor movements such as hand flapping, rocking, spinning, or finger flicking — often serve a self-regulatory function
  • Insistence on sameness: Rigid routines; significant distress if a preferred order, route, or ritual is disrupted
  • Restricted interests: Intense focus on specific topics (trains, numbers, specific TV shows) to a degree that interferes with daily functioning or social interaction
  • Self-injurious behavior (SIB): Head banging, hand biting, or skin picking may occur, particularly in response to distress, sensory overload, or communication frustration

Sensory sensitivities

Sensory processing differences are among the most clinically significant features for nursing practice. Individuals with ASD may be:

  • Hypersensitive (over-responsive): Fluorescent lighting, specific sounds (monitors, alarms, overhead pages), certain textures, smells, or tastes can trigger significant behavioral dysregulation. This is not defiance — it is a neurological response to overwhelming sensory input
  • Hyposensitive (under-responsive): May appear indifferent to pain, temperature, or other stimuli. A child with ASD may have a broken bone without crying. This directly affects pain assessment

Comorbidities

Comorbid condition Estimated prevalence in ASD Clinical nursing relevance
Intellectual disability ~30% Affects communication; requires adapted patient education; dispel the myth that all ASD includes intellectual disability — ~70% do not have it
Epilepsy / seizure disorder ~20–25% Seizure precautions; anti-epileptic medication management; see seizure nursing
ADHD ~30–50% Attention, impulsivity; medication interactions between stimulants and ASD-related medications
Anxiety disorders ~40–50% Hospitalization is a significant anxiety trigger; environmental modification is a nursing priority
Depression ~20–30% (higher in adults) May present atypically; behavioral changes may signal depression
Gastrointestinal disorders ~24–70% (range varies by study) Constipation, diarrhea, GERD are common; behavioral changes may signal GI pain
Sleep disorders ~40–80% Sleep disruption worsens behavioral dysregulation; melatonin often first-line

Nursing assessment

Initial approach

The assessment of a patient with ASD should begin before entering the room. Gather information from caregivers about:

  • Communication style: Does the patient use spoken language? If so, how reliably? Do they use augmentative and alternative communication (AAC) — a speech-generating device, picture exchange system (PECS), or sign language?
  • Sensory sensitivities: What environments or stimuli trigger distress? What helps?
  • Behavioral baseline: What does the patient look like when calm? What are early signs of distress?
  • Routines: What routines are critical to the patient’s regulation?
  • Preferred reinforcers: What does the patient respond well to?

This is not optional background — it is the foundation of safe care. A thorough head-to-toe assessment must be modified for the ASD patient.

Developmental screening and diagnostic tools

Nurses do not diagnose ASD, but understanding the tools used is NCLEX-relevant and essential for triage and referral. The pediatric nursing reference provides broader developmental screening context.

  • M-CHAT-R (Modified Checklist for Autism in Toddlers, Revised): Validated screening tool for children 16–30 months; completed by parents; positive screen triggers referral for diagnostic evaluation, not diagnosis
  • ADOS-2 (Autism Diagnostic Observation Schedule, 2nd Edition): Gold-standard diagnostic assessment conducted by trained specialists; not a nursing tool but nurses should understand the referral pathway
  • Developmental surveillance: At every well-child visit, the nurse asks developmental questions and flags delays. Any regression in language or social skills is a red flag requiring urgent referral

Communication assessment

  • Determine if the patient is verbal, minimally verbal, or nonverbal
  • Identify the patient’s AAC system if applicable — and ensure it is available at all times during the hospitalization
  • Assess reading ability (some nonverbal ASD individuals are skilled readers)
  • Note preferred communication modality

Critical: Never remove an AAC device from a patient. It is the equivalent of removing a patient’s voice. Document its location and ensure it stays with the patient at all times.

Pain assessment — altered pain expression

Pain assessment is a high-priority challenge in ASD nursing care. Altered sensory processing means:

  • Some patients may be hypersensitive to pain and react strongly to minor procedures
  • Others may be hyposensitive and not verbalize or behaviorally indicate significant pain
  • Behavioral changes — increased stereotypy, self-injurious behavior, withdrawal, irritability, or unusual quietness — may be the primary indicators of pain

Use behavioral pain scales rather than self-report scales alone:

  • FLACC scale (Face, Legs, Activity, Cry, Consolability) — appropriate for nonverbal children
  • r-FLACC (revised FLACC): Modified version with behavioral indicators validated for children with cognitive and developmental disabilities
  • Behavioral observation: Caregiver input is essential — they know the patient’s behavioral baseline

Elopement / wandering safety assessment

Up to 49% of children with ASD elope (attempt to leave a safe environment, often without awareness of danger). Assess:

  • History of elopement
  • Awareness of environmental hazards
  • Response to name and direction
  • Physical ability — many individuals with ASD are physically capable and fast

Elopement is a patient safety priority in inpatient settings. Implement fall/safety precautions accordingly.


Nursing interventions

Environmental modifications

The hospital environment is inherently dysregulating for patients with ASD. Evidence-based adaptations include:

  • Lighting: Dim or cover fluorescent lights where possible; use natural or incandescent lighting
  • Noise: Close the room door; minimize overhead page exposure; silence non-essential alarms at the bedside when safe to do so
  • Stimulation: Reduce unnecessary staff foot traffic; limit the number of new faces; keep the environment predictable
  • Private room: Assign a private room whenever possible to minimize sensory and social overload

Routine and predictability

  • Establish and maintain a consistent daily schedule
  • Prepare the patient in advance for each procedure or change — explain steps before beginning, not during
  • Use visual schedules (a sequence of pictures or words showing what will happen next) — post them where the patient can see
  • Avoid unexpected changes; if changes are unavoidable, prepare the patient with as much advance notice as possible

Communication strategies

  • Use clear, simple, concrete language
  • Give one instruction at a time
  • Allow significant processing time — wait at least 10 seconds for a response before repeating
  • Avoid idioms, sarcasm, and figurative language
  • Use visual supports: picture cards, written instructions, first-then boards (“First we do X, then we do Y”)
  • Speak calmly and quietly; vocal tone carries significant weight
  • Direct questions to the patient first, even if their response capacity is limited — do not speak about them as if they are not present

Procedure preparation

  • Explain each step of a procedure before starting, using visual supports if available
  • Use a “social story” approach if time allows: a brief narrative with pictures showing the patient what the procedure involves
  • Allow sensory preview where possible (let the patient touch equipment, hear sounds before they occur)
  • Minimize physical restraint — restraint is highly distressing for individuals with ASD and should be a last resort with documented clinical justification
  • Consider desensitization: for planned procedures, a pre-admission visit or video preview of the environment can reduce anticipatory anxiety

Behavioral support

  • Reinforce positive behavior — acknowledge calm, cooperation, and engagement specifically
  • Do not use punitive or shame-based responses to behavioral dysregulation
  • Identify the function of challenging behavior: Is it sensory-related? Communication-based (expressing pain or discomfort)? Avoidance of an aversive stimulus?
  • Collaborate with ABA therapists or behavioral support teams if available; follow established behavioral support plans consistently

Wandering and elopement precautions

  • Bed exit alarms where indicated
  • Door alarms for exit doors near the unit
  • Consistent use of ID wristbands
  • Staff awareness and consistent room assignment
  • Communication with the patient and family about the hospital’s physical environment

Family-centered care

Parents and caregivers are essential partners — they hold clinical knowledge about the patient that no chart can replicate. Family-centered care is the standard framework for pediatric ASD nursing. See the pediatric nursing reference for broader context.

  • Include parents/caregivers in care planning and procedures
  • Ask about established routines and replicate them as closely as possible
  • Acknowledge caregiver expertise — they know this patient
  • Assess for caregiver burnout: ASD caregiving is high-demand. Connect families with community resources, respite services, and support organizations (Autism Speaks, Autism Society of America, local regional centers)
  • Provide written discharge instructions with visual supports — verbal-only instructions are inadequate

Pharmacological management

No medication treats the core symptoms of ASD. Pharmacotherapy targets comorbid conditions. This is NCLEX-critical. Compare with the range of medications covered in the drug classifications nursing reference.

Medication Target symptom / indication FDA approval status Key nursing considerations
Risperidone (Risperdal) Irritability associated with ASD (aggression, self-injury, temper tantrums) FDA-approved for ASD irritability — ages 5 and up Weight gain, sedation, extrapyramidal symptoms, metabolic monitoring; monitor for tardive dyskinesia with long-term use
Aripiprazole (Abilify) Irritability associated with ASD FDA-approved for ASD irritability — ages 6 and up Lower weight gain than risperidone; akathisia; monitor for suicidality (black box warning in children/adolescents); preferred when metabolic risk is a concern
SSRIs (fluoxetine, sertraline) Anxiety, depression, repetitive behaviors Off-label for ASD; FDA-approved for anxiety/depression in respective age groups May reduce repetitive behaviors in some patients; monitor for behavioral activation (paradoxical agitation) — more common in ASD than in neurotypical patients; black box warning for suicidality in pediatric patients
Stimulants (methylphenidate, amphetamine salts) ADHD comorbidity — inattention, hyperactivity, impulsivity FDA-approved for ADHD; off-label when used in ASD+ADHD context Reduced efficacy and higher rate of side effects in ASD compared to neurotypical ADHD; monitor for appetite suppression, irritability, and tics
Melatonin Sleep onset difficulties Over-the-counter supplement; not FDA-regulated as a drug Commonly used first-line for sleep disturbances in ASD; low side effect profile; typical doses 0.5–5 mg at bedtime; educate families about appropriate formulations for children
Anti-epileptic drugs (valproate, lamotrigine, levetiracetam) Seizure disorder comorbidity FDA-approved for seizure types; used in ASD patients with comorbid epilepsy Seizure management follows standard epilepsy protocols; note that valproate is teratogenic and should be used with extreme caution in females of reproductive age; see seizure nursing

Applied Behavior Analysis (ABA)

ABA is the most extensively researched and evidence-based intervention for ASD. It applies principles of behavioral psychology to increase functional skills and reduce behaviors that limit participation.

Core ABA principles relevant to nursing:

  • Positive reinforcement: Desired behaviors are followed by meaningful rewards (preferred items, activities, praise), increasing the likelihood of repetition
  • Antecedent modification: Changing environmental factors that trigger challenging behavior (the nursing interventions above are largely antecedent-based)
  • Functional behavior assessment (FBA): Systematic process to identify the function (purpose) of a challenging behavior — sensory, escape, attention-seeking, or access to a preferred item
  • Prompting and prompt fading: Using physical, gestural, or verbal cues to guide behavior, then gradually reducing support as the skill is learned

Nursing role in ABA: When a patient has an established ABA behavior intervention plan (BIP), nurses must implement it consistently. Inconsistency undermines the behavioral program. Ask the family for the plan, read it, and follow it. This is not optional — it is part of the care plan.


ASD across the lifespan — development and transition

Early development and the neonatal and early infancy period

ASD is not diagnosable at birth but early developmental monitoring identifies children at risk. Red flags in the first two years include:

  • No babbling by 12 months
  • No single words by 16 months
  • No two-word phrases by 24 months
  • Any regression in language or social skills at any age — this is always a referral trigger

Similarly, conditions affecting early brain development — such as hypoxic-ischemic encephalopathy or neonatal seizures — carry elevated risk for later neurodevelopmental conditions. Familiarity with the neonatal nursing reference provides context for understanding developmental trajectories.

The nurse’s role in early identification is critical: ASD outcomes improve significantly with early intervention.

School age and adolescence

  • IEP (Individualized Education Program): Children with ASD are entitled to a free appropriate public education (FAPE) under the Individuals with Disabilities Education Act (IDEA). Nurses in school and outpatient settings may be involved in IEP meetings and health-related accommodations
  • Bullying risk is significantly elevated in school-age children with ASD — screen for victimization and its mental health consequences
  • Adolescence brings increased social complexity and heightened risk for anxiety and depression; many teens with ASD (particularly Level 1) are not diagnosed until this period

Transition to adulthood

Transition from pediatric to adult services is a documented clinical challenge for ASD populations. Legal protections under IDEA end at age 22. Nursing considerations:

  • Begin transition planning no later than age 14 under IDEA requirements
  • Assess for independent living skills: medication management, nutrition, safety awareness
  • Connect young adults and families with vocational rehabilitation services, supported employment, and adult disability services early — waitlists can be years long
  • Healthcare transition: transfer of care to adult providers must be planned, not assumed. Many adult care providers have limited ASD training

The contrast with conditions such as cerebral palsy is instructive: both are lifelong neurodevelopmental conditions requiring coordinated transition planning.


Differential considerations: what to distinguish on NCLEX

Condition Key differentiating features How to distinguish from ASD
Intellectual disability (ID) Global cognitive and adaptive deficits; social communication may be limited but is not the defining feature; no restricted/repetitive behaviors required for diagnosis ASD and ID can coexist; ASD requires social communication deficits + RRBs; ID is diagnosed by cognitive and adaptive functioning assessment alone. ~30% of ASD patients also have ID
ADHD Inattention, hyperactivity, impulsivity; social difficulties are secondary to attention; no restricted/repetitive behaviors as a defining feature; no insistence on sameness ASD has persistent social communication deficits and RRBs as core features; ADHD and ASD frequently co-occur; both can present with behavioral dysregulation but the triggers and patterns differ
Language disorder Deficits in language acquisition and use; social communication difficulties may be present but are secondary to language impairment ASD social deficits persist even in individuals with intact language; nonverbal communication deficits (eye contact, gesture) are a core ASD feature not explained by language disorder alone
Social anxiety disorder Fear and avoidance of social situations due to anxiety about evaluation; social communication skills are intact when anxiety is absent ASD social deficits are present across all contexts regardless of anxiety level; restricted/repetitive behaviors are not a feature of social anxiety
Childhood-onset schizophrenia Psychosis (hallucinations, delusions, disorganized speech); onset typically after age 7; developmental history prior to symptom onset is typically normal ASD symptoms are present from early development; psychosis is not a feature of ASD; ASD patients do not typically have hallucinations as a presenting feature (though anxiety or sensory experiences can sometimes be misinterpreted)

NCLEX high-yield points

The following 15 points are among the most commonly tested ASD concepts on NCLEX. Review each carefully.

1. Vaccines do not cause autism. This is established clinical consensus, confirmed by multiple large-scale studies involving millions of children. The 1998 Wakefield study was retracted and found to be fraudulent. Nurses must be prepared to educate families clearly and confidently on this point.

2. DSM-5 replaced former subtypes — all are now ASD. Asperger’s disorder, autistic disorder, and PDD-NOS no longer exist as separate diagnoses under DSM-5. All are classified as ASD with a severity level (1, 2, or 3). Severity is rated separately for social communication and for RRBs.

3. Risperidone and aripiprazole are the only FDA-approved medications for ASD — and they treat irritability, not core symptoms. No medication treats the core ASD symptoms of social communication deficits or restricted/repetitive behaviors. Risperidone is FDA-approved for irritability in ASD ages 5+; aripiprazole for irritability ages 6+.

4. Approximately 20–25% of individuals with ASD have epilepsy — always assess for seizure history. This comorbidity requires seizure precautions, anti-epileptic medication management, and awareness of how seizure activity may present atypically in a patient with ASD.

5. Elopement risk is high — up to 49% of children with ASD elope. This is a documented patient safety risk requiring active precautions in inpatient settings. Assess for history at admission and implement appropriate environmental and monitoring precautions.

6. Pain may not be verbalized — use behavioral pain scales. Altered sensory processing means standard self-report pain scales are unreliable for many patients with ASD. Use the FLACC or r-FLACC, incorporate behavioral observations, and include caregiver input. A patient with ASD may have a fracture without crying.

7. Sensory sensitivities are neurological, not behavioral. Fluorescent lights, loud alarms, certain textures, and unexpected touch can trigger significant dysregulation. This is not noncompliance or defiance — it is a physiological response. The nurse’s job is to modify the environment, not manage the behavior punitively.

8. Avoid idioms and figurative language. “Take a seat,” “it’ll only take a second,” “we’re going to draw some blood” — these phrases can confuse or alarm a patient with ASD who interprets language literally. Use clear, concrete, literal language in all patient communication.

9. Do not remove an AAC device. A patient’s speech-generating device, PECS system, or any AAC technology is their primary communication tool. Removing it or failing to ensure it is charged, accessible, and functioning is a clinical safety issue. Document its presence and ensure it travels with the patient to all procedures.

10. Written and visual discharge instructions are required — not optional. Verbal discharge instructions alone are inadequate for patients with ASD and their caregivers. Provide written instructions with simple language and, where possible, visual supports. This is a patient safety standard.

11. ~30% of ASD patients also have intellectual disability; ~70% do not. This is a commonly tested misconception. ASD does not imply intellectual disability. Many individuals with ASD have average or above-average intelligence. Assumptions about cognitive ability based on ASD diagnosis alone are clinically inaccurate.

12. Melatonin is commonly used first-line for sleep disturbances in ASD. Sleep disorders affect 40–80% of individuals with ASD. Melatonin is the typical first-line approach before sedating medications. Educate families about appropriate formulations and dosing in pediatric patients.

13. Aripiprazole vs risperidone: choose aripiprazole when metabolic risk is a concern. Both are FDA-approved for irritability in ASD. Aripiprazole has a lower weight gain and metabolic side effect profile than risperidone. On NCLEX, if the question specifies a concern about weight or metabolic syndrome, aripiprazole is the preferred agent.

14. Behavioral activation is a key SSRI risk in ASD. SSRIs are used off-label for anxiety and repetitive behaviors in ASD. Paradoxical behavioral activation — increased agitation, impulsivity, and irritability — occurs more frequently in ASD patients than in neurotypical patients. This is a priority nursing monitoring point when SSRIs are initiated.

15. Family-centered care is the framework — caregivers are clinical partners. Parents and caregivers possess detailed knowledge of the patient’s communication, behavioral baseline, sensory needs, and effective strategies. Their input is not supplementary — it is a core clinical resource. Excluding caregivers from care planning is a nursing error in the ASD context.


Family education priorities

When preparing for discharge or providing family education in any care setting:

  • Explain the sensory-based rationale for environmental modifications — families often need to advocate for these accommodations in other settings
  • Reinforce the ABA plan if one exists — consistency across environments is critical for behavioral progress
  • Address the vaccine question directly if any uncertainty exists — provide factual, evidence-based information without judgment
  • Community resources: Autism Speaks (autismspeaks.org), Autism Society of America, local regional centers and state developmental disability agencies, SPARK research registry for families interested in ASD research
  • Caregiver burnout: ASD caregiving is among the highest-burden caregiver roles documented in the literature. Screen for burnout, depression, and support needs. Respite care resources vary by state; connect families with their regional center or state disability office
  • IEP/IDEA rights: Parents have legal rights under IDEA including the right to an IEP, the right to dispute placement decisions, and the right to request evaluations. Nurses in school and community settings can help families understand and exercise these rights

Content reviewed for clinical accuracy against DSM-5 (American Psychiatric Association, 2013), CDC ADDM Network 2023 surveillance data, AAP Clinical Practice Guideline for ASD identification (2020), NCSBN NCLEX-RN test plan, and NIH/NIMH clinical guidance on ASD pharmacotherapy and intervention.